Arkolith/Insider Trading/TMDX/Form 4

Khayal Tamer I

Chief Commercial OfficerTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Nov 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$89K
Net Open-Market Flow
-$89K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 1, 2024Option exercise(M)1K$13.28$14K22K
Nov 1, 2024Sell(S)1K$82.64$89K21K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 1, 2024Option exercise(M)1K—$017K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-121525) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML